rs1801177
This is a variant in the LPL gene that changes a aspartate to an asparagine.
▶GWAS Catalog Trait Associations (4)
Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.
GWAS Catalog Trait Associations (4)
Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.
high density lipoprotein cholesterol measurement
triglyceride measurement
apolipoprotein A 1 measurement
apolipoprotein B measurement
▶ClinVar annotation
Cardiovascular phenotype; Coronary heart disease; Hyperlipidemia, familial combined, LPL related (FCHL3); Hyperlipidemia, familial combined, susceptibility to; Hyperlipoproteinemia, type I; LPL-related disorder; not specified
View on ClinVar →About LPL
LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism. [provided by RefSeq, Jul 2008]
View all LPL variants →Gene information from NCBI Gene. Variant classifications from ClinVar.
Community Wiki
No community notes yet for this variant. Sign in to start one.
Comments
Sign in to join the discussion.
Loading comments…